Biocompatible Component Nanoparticle Surface Osseointegration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current dental implants face challenges in achieving strong osseointegration due to issues with surface roughness and chemical compatibility, leading to potential failure from brittle coatings and unpredictable tissue responses.
Innovation Solution
A biocompatible component with a surface comprising titanium dioxide nanoparticles of less than 25 nm in size, applied through electrospray-scanning mobility particle sizer technology, which induces early hydroxyapatite nucleation and enhances tissue regeneration by creating a porous, electrochemically active surface for improved cell attachment and bone formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a layer of ceramic material such as hydroxyapatite is applied on the implant surface to improve bonding to bone, then the chemical compatibility and bone attachment are improved, but the coating becomes brittle and may flake or break off due to stronger bond between bone and coating than between coating and implant
Solution Approach 1:
The patent removes the separate hydroxyapatite coating layer and instead incorporates calcium phosphate directly into the titanium alloy substrate, creating a biocompatible metal alloy that inherently provides both structural strength and bone attachment capability without a brittle surface coating
Solution Approach 2:
The patent creates a composite material system by incorporating calcium phosphate particles within the titanium alloy matrix, combining the mechanical strength of titanium with the bone-binding properties of calcium phosphate to achieve both structural integrity and biological compatibility in a single monolithic structure
2Strength
If the surface roughness is increased to provide larger contact and attachment area between implant and bone tissue, then the mechanical retention is improved, but the osseointegration may be compromised due to unpredictable tissue response to rough surfaces
Solution Approach 1:
The patent applies different surface characteristics at different scales: macroscopic smoothness for predictable tissue response and microscopic roughness features for increased surface area and mechanical retention, achieving both goals simultaneously through multi-scale surface engineering
Solution Approach 2:
The patent modifies surface parameters by controlling the size, distribution, and morphology of calcium phosphate particles within the alloy matrix, creating optimal surface characteristics that enhance bone attachment while maintaining predictable osseointegration responses
3Reliability
If protein coatings are applied to the implant surface to enhance biocompatibility, then the tissue attachment is improved, but specific sterilization and storage conditions are required to maintain biological activity and host tissue response may be unpredictable
Solution Approach 1:
The patent replaces fragile protein coatings with a robust inorganic calcium phosphate-based alloy surface that is stable under standard sterilization conditions and does not require special handling, effectively using a more durable but simpler material to achieve the same biological function
Solution Approach 2:
The patent changes the chemical composition parameters of the implant surface by incorporating calcium phosphate, which provides inherent osteoconductivity and bone attachment capabilities without the instability and sensitivity issues associated with organic protein coatings
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticle-coated surface promotes early apatite nucleation and osseointegration, offering a stronger and more stable bond between the implant and bone tissue, reducing the risk of coating failure and enhancing long-term implant integration.
Implementation Method 1
induces early hydroxyapatite nucleation
Implementation Method 2
creating a porous, electrochemically active surface
Implementation Method 3
applied through electrospray-scanning mobility particle sizer technology
Data Source
Figure 1
Figure 2a~2e
Figure 3a~3d
AI summary
The invention provides a biocompatible component having a surface intended for contact with living tissue, wherein the surface comprises particles of metal oxide, said particleshaving an average particle size of less than 100 nm. A method for the production of such biocompatible component is also provided. It was found that the bioactivity of the biocompatible component was increased compare to a reference in that it induced earlier apatite nucleation in vitro. It is believed that by the biocompatible component may induce early hydroxyapatite nucleation in vivo and thus promote osseointegration of an implant.